CTLS TARGET A CURE CLINICAL TRIALS LABORATORY SERVICES

Serial Number 88581298
Registration 6017576
700

Registration Progress

Application Filed
Aug 16, 2019
Under Examination
Approved for Publication
Jan 7, 2020
Published for Opposition
Jan 7, 2020
Registered
Mar 24, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20200324)
Due: Mar 24, 2026 49 days

Trademark Image

CTLS TARGET A CURE CLINICAL TRIALS LABORATORY SERVICES

Basic Information

Serial Number
88581298
Registration Number
6017576
Filing Date
August 16, 2019
Registration Date
March 24, 2020
Published for Opposition
January 7, 2020
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 24, 2020
Registration
Registered
Classes
044

Rights Holder

BioIVT Holdings, LLC

16
Address
Suite 400
2711 Centerville Rd.
Wilmington, DE 19808

Ownership History

BioIVT Holdings, LLC

Original Applicant
16
Wilmington, DE

BioIVT Holdings, LLC

Owner at Publication
16
Wilmington, DE

BioIVT Holdings, LLC

Original Registrant
16
Wilmington, DE

Legal Representation

Attorney
Chun T. Wright

USPTO Deadlines

Next Deadline
49 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200324)
Due Date
March 24, 2026
Grace Period Ends
September 24, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Sep 19, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 19, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 19, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 24, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Sep 27, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 27, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 27, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 27, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 27, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 24, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 7, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 7, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 18, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 2, 2019 ALIE A ASSIGNED TO LIE Loading...
Nov 26, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 22, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 22, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 22, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 22, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 18, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 4, 2019 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 3, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 20, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
collecting and preserving donations of blood and other biofluids from consented donors for use in scientific and medical research
First Use Anywhere: Jul 23, 2019
First Use in Commerce: Jul 23, 2019

Additional Information

Design Mark
The mark consists of the letters "CTLS" in black stylized letters above the words "Target a cure". in red stylized letters with a stylized design of a red drop of blood at the center of three concentric circles appearing in the colors white, pink and red on one side and a red straight vertical line and the words "clinical trials laboratory services" in black stylized letters appearing on the other side.
Color Claim
The colors red, black, white and pink are claimed as a feature of the mark.
Pseudo Mark
CLINICAL TRIALS LABORATORY SERVICES TARGET A CURE CLINICAL TRIALS LABORATORY SERVICES

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CLINICAL TRIALS LABORATORY SERVICES"